A physiologically based pharmacokinetic modeling approach to predict disease-drug interactions: Suppression of CYP3A by IL-6

导出原文传递

翻译打印收藏纠错

作者： MacHavaram,K.K. ^[1] ; Almond,L.M. ^[2] ; Rostami-Hodjegan,A. ^[3] ; Gardner,I. ^[4] ; Jamei,M. ^[5] ; Tay,S. ; Wong,S. ; Joshi,A. ; Kenny,J.R.

作者单位： Simcyp (A Certara Company), Sheffield, United Kingdom, Department of Drug Metabolism and ^[1] Department of Drug Metabolism and Pharmacokinetics, Genentech, South San Francisco, CA, United ^[2] Department of Clinical Pharmacology, Genentech, South San Francisco, CA, United States ^[3] Simcyp (A Certara Company), Sheffield, United Kingdom ^[4] Simcyp (A Certara Company), Sheffield, United Kingdom, School of Pharmacy and Pharmaceutical ^[5]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Clinical Pharmacology and Therapeutics

2013年94卷2期

260-268页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A physiologically based pharmacokinetic modeling approach to predict disease-drug interactions: Suppression of CYP3A by IL-6

Clinical Pharmacology and Therapeutics

相似文献

Clinical Pharmacology and Therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A physiologically based pharmacokinetic modeling approach to predict disease-drug interactions: Suppression of CYP3A by IL-6

Clinical Pharmacology and Therapeutics

相似文献

Clinical Pharmacology and Therapeutics

相关期刊

检索历史清除